康希诺涨5.01% 政策利好与技术突破推动股价上行

智选洞察2025-07-30

康希诺股价大幅上涨，最新价84.27元/股，涨幅5.01%。政策利好与技术突破催动资金博弈康希诺近期净流入源于政策与技术双重变量共振。7月创新药专项政策落地叠加吸入式疫苗技术突破预期，直接激活市场情绪，7月24日单日主力资金净流入超2600万元。政策利好吸引短线资金快速进场，但2025年前三季度1154万元亏损压力尚未解除，叠加二季度销售淡季影响，部分机构选择在反弹中兑现收益。截至7月28日，该股...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555107095?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-30 10:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2555107095","market":"sh","top_or_hot":-1,"title":"康希诺涨5.01% 政策利好与技术突破推动股价上行","media":"智选洞察","content":"<div>\n<p>康希诺股价大幅上涨，最新价84.27元/股，涨幅5.01%。政策利好与技术突破催动资金博弈康希诺近期净流入源于政策与技术双重变量共振。7月创新药专项政策落地叠加吸入式疫苗技术突破预期，直接激活市场情绪，7月24日单日主力资金净流入超2600万元。政策利好吸引短线资金快速进场，但2025年前三季度1154万元亏损压力尚未解除，叠加二季度销售淡季影响，部分机构选择在反弹中兑现收益。截至7月28日，该股...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730100642a46a94ac&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康希诺涨5.01% 政策利好与技术突破推动股价上行</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康希诺涨5.01% 政策利好与技术突破推动股价上行\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-30 10:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730100642a46a94ac&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>康希诺股价大幅上涨，最新价84.27元/股，涨幅5.01%。政策利好与技术突破催动资金博弈康希诺近期净流入源于政策与技术双重变量共振。7月创新药专项政策落地叠加吸入式疫苗技术突破预期，直接激活市场情绪，7月24日单日主力资金净流入超2600万元。政策利好吸引短线资金快速进场，但2025年前三季度1154万元亏损压力尚未解除，叠加二季度销售淡季影响，部分机构选择在反弹中兑现收益。截至7月28日，该股...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730100642a46a94ac&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730100642a46a94ac&s=b","article_id":"2555107095","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730100642a46a94ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555107095","pubTimestamp":1753841191,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"康希诺股价大幅上涨，最新价84.27元/股，涨幅5.01%。政策利好与技术突破催动资金博弈康希诺近期净流入源于政策与技术双重变量共振。政策利好吸引短线资金快速进场，但2025年前三季度1154万元亏损压力尚未解除，叠加二季度销售淡季影响，部分机构选择在反弹中兑现收益。截至7月28日，该股单日振幅达17.11%，量比攀升至2.27，显示多空分歧进入白热化阶段。CDMO业务2024年营收同比增长12.3%，技术平台价值逐步释放。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688185":"康希诺","BK0239":"医药制造"},"translate_title":"CanSino rose 5.01%, favorable policies and technological breakthroughs pushed the stock price up","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688185":1},"content_text":"康希诺股价大幅上涨，最新价84.27元/股，涨幅5.01%。政策利好与技术突破催动资金博弈康希诺近期净流入源于政策与技术双重变量共振。7月创新药专项政策落地叠加吸入式疫苗技术突破预期，直接激活市场情绪，7月24日单日主力资金净流入超2600万元。政策利好吸引短线资金快速进场，但2025年前三季度1154万元亏损压力尚未解除，叠加二季度销售淡季影响，部分机构选择在反弹中兑现收益。截至7月28日，该股单日振幅达17.11%，量比攀升至2.27，显示多空分歧进入白热化阶段。管线商业化进程主导估值重构长期来看，康希诺估值锚定于核心疫苗管线的商业化兑现能力。MCV4疫苗适用年龄扩展至6周岁后，理论市场容量提升50%；若PCV13i疫苗年内获批或带来超30亿元增量空间。CDMO业务2024年营收同比增长12.3%，技术平台价值逐步释放。当前动态市盈率-94.64倍反映市场对扭亏节奏存疑，市净率4.26倍虽处两年低位，仍高于生物制品板块中位值。国泰海通证券给予的66.73元目标价已被突破，若三季度疫苗放量带动营收向机构预测的10.53亿元靠拢，或打开估值修复窗口，但产能爬坡与海外临床进展仍需持续验证。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555107095","isCrawlerRequest":true}